-
Real Madrid apologise to China over Mbappe comments
-
'Eat the rich': Indonesians protest against graft, wildfires
-
Three killed by storm in southern India
-
Netanyahu bloc leads as Israeli votes counted, but no majority
-
China says takes Mbappe apology 'seriously' after Mao remark
-
Cyclone eases after lashing India coast, no deaths reported
-
Flavio Bolsonaro on way to Ecuador from Argentina after fleeing Brazil
-
AI chip giant SK hynix posts seven-fold surge in quarterly operating profit
-
Netanyahu bloc leads after half of Israeli votes counted but no majority
-
Two hundred 'Cruise for life' passengers stranded in Cambodia
-
India vows action after first cheetah shot dead
-
Pierce Brosnan and Helen Mirren on the joys of filming 'MobLand'
-
'Now or Never': Ethiopia influencers push for Eritrea invasion
-
S.African activists push back on data centre rush
-
Mbappe furore rages on in China, but Mao comments censored
-
Judges set to rule on Australian mushroom killer's appeal
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
-
Syria reopens Jordan border crossing after mending ties
-
Rays win thriller to thwart Brewers in World Series
-
Cyclone Arnab lashes India coast, no deaths reported
-
Reigning champ Knicks earn first win against Pistons
-
Trump tamed after US midterms? Europe doubts it
-
Runners swap streets for shopping malls as haze chokes Singapore
-
Tech stocks soar as SK hynix adds to rising AI confidence
-
Billionaire Ambani's Jio to debut after record India IPO
-
Sri Lanka's Tamil farmers fight to reclaim land after civil war
-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
-
Trump drastically loosens oil and gas methane rules
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
French Senate weighs bill to make protesters pay for unrest damage
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
Long Covid symptoms affects one in eight, study suggests
One in eight people who get coronavirus develop at least one symptom of long Covid, one of the most comprehensive studies on the condition to date suggested on Thursday.
With more than half a billion coronavirus cases recorded worldwide since the start of the pandemic, there has been rising concern about the lasting symptoms seen in people with long Covid.
However almost none of the existing research has compared long Covid sufferers with people who have never been infected, making it possible that some of the health problems were not caused by the virus.
A new study published in The Lancet journal asked more than 76,400 adults in the Netherlands to fill out an online questionnaire on 23 common long Covid symptoms.
Between March 2020 and August 2021, each participant filled out the questionnaire 24 times.
During that period, more than 4,200 of them -- 5.5 percent -- reported catching Covid.
Of those with Covid, over 21 percent had at least one new or severely increased symptom three to five months after becoming infected.
However nearly nine percent of a control group which did not have Covid reported a similar increase.
This suggested that 12.7 percent of those who had Covid -- around one in eight -- suffered from long-term symptoms, the study said.
The research also recorded symptoms before and after Covid infection, allowing the researchers to further pinpoint exactly what was related to the virus.
It found that common long Covid symptoms include chest pain, breathing difficulties, muscle pain, loss of taste and smell, and general fatigue.
- 'Major advance' -
One of the study's authors, Aranka Ballering of the Dutch University of Groningen, said long Covid was "an urgent problem with a mounting human toll".
"By looking at symptoms in an uninfected control group and in individuals both before and after SARS-CoV-2 infection, we were able to account for symptoms which may have been a result of non-infectious disease health aspects of the pandemic, such as stress caused by restrictions and uncertainty," she said.
The authors of the study said its limitations included that it did not cover later variants, such as Delta or Omicron, and did not collect information about some symptoms such as brain fog, which have since been considered a common sign of long Covid.
Another study author, Judith Rosmalen, said "future research should include mental health symptoms" such as depression and anxiety, as well as aspects like brain fog, insomnia and a feeling of malaise after even minor exertion.
Christopher Brightling and Rachael Evans, experts from Britain's Leicester University who were not involved in the study, said it was "a major advance" on previous long Covid research because it had an uninfected control group.
"Encouragingly, emerging data from other studies" suggests there is a lower rate of long Covid in people who have been vaccinated or infected with the Omicron variant, they said in a linked Lancet comment.
K.Brown--BTB